VHL and neoplasm: The von Hippel-Lindau (VHL) tumor suppressor is responsible for substrate recognition in the Cullin-RING ubiqutin ligase complex, which is composed of Cullin 2, elongin B, elongin C, and Rbx1, entitled as Cul2-elonginB/C (CBC) complex [1–4].